Literature DB >> 25419041

Glyco-modification of protein with O-cyanate chain-end functionalized glycopolymer via isourea bond formation.

Valentinas Gruzdys1, Hailong Zhang1, Xue-Long Sun1.   

Abstract

Glycoengineering aimed at addition of carbohydrates to proteins is an attractive approach to alter pharmacokinetic properties of proteins such as enhancing stability and prolonging the duration of action. We report a novel protein glyco-modification of BSA and recombinant thrombomodulin with O-cyanate chain-end functionalized glycopolymer via isourea bond formation. The protein glycoconjugates were confirmed by SDS-PAGE, western blot, and MALDI-TOF Mass Spectrometry. Protein C activation activity of the glyco-modified recombinant thrombomodulin was confirmed, proving no interference to activity from the glycopolymer modification. The isourea bond formation under mild conditions was demonstrated as an alternative method for protein modification with polymers.

Entities:  

Keywords:  Carbohydrate; cyanate; glycopolymer; isourea; protein; thrombomodulin

Year:  2014        PMID: 25419041      PMCID: PMC4235998          DOI: 10.1080/07328303.2014.922189

Source DB:  PubMed          Journal:  J Carbohydr Chem        ISSN: 0732-8303            Impact factor:   1.667


  18 in total

Review 1.  Protein-polymer conjugates: synthetic approaches by controlled radical polymerizations and interesting applications.

Authors:  Gregory N Grover; Heather D Maynard
Journal:  Curr Opin Chem Biol       Date:  2010-11-10       Impact factor: 8.822

2.  Site-directed conjugation of "clicked" glycopolymers to form glycoprotein mimics: binding to mammalian lectin and induction of immunological function.

Authors:  Jin Geng; Giuseppe Mantovani; Lei Tao; Julien Nicolas; Gaojian Chen; Russell Wallis; Daniel A Mitchell; Benjamin R G Johnson; Stephen D Evans; David M Haddleton
Journal:  J Am Chem Soc       Date:  2007-11-17       Impact factor: 15.419

3.  In vitro anticoagulant properties of a minimum functional fragment of human thrombomodulin and in vivo demonstration of its benefit as an anticoagulant in extracorporeal circulation using a monkey model.

Authors:  M Suzuki; M Mohri; S Yamamoto
Journal:  Thromb Haemost       Date:  1998-02       Impact factor: 5.249

4.  The last three consecutive epidermal growth factor-like structures of human thrombomodulin comprise the minimum functional domain for protein C-activating cofactor activity and anticoagulant activity.

Authors:  M Zushi; K Gomi; S Yamamoto; I Maruyama; T Hayashi; K Suzuki
Journal:  J Biol Chem       Date:  1989-06-25       Impact factor: 5.157

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 6.  Glycoengineering: the effect of glycosylation on the properties of therapeutic proteins.

Authors:  Angus M Sinclair; Steve Elliott
Journal:  J Pharm Sci       Date:  2005-08       Impact factor: 3.534

Review 7.  Regulation and functions of the protein C anticoagulant pathway.

Authors:  C T Esmon; J M Gu; J Xu; D Qu; D J Stearns-Kurosawa; S Kurosawa
Journal:  Haematologica       Date:  1999-04       Impact factor: 9.941

8.  Chemical coupling of proteins to agarose.

Authors:  J Porath; R Axen; S Ernback
Journal:  Nature       Date:  1967-09-30       Impact factor: 49.962

9.  Bio-inspired liposomal thrombomodulin conjugate through bio-orthogonal chemistry.

Authors:  Hailong Zhang; Jacob Weingart; Rui Jiang; Jianhao Peng; Qingyu Wu; Xue-Long Sun
Journal:  Bioconjug Chem       Date:  2013-03-15       Impact factor: 4.774

10.  Design and synthesis of biotin chain-terminated glycopolymers for surface glycoengineering.

Authors:  Xue-Long Sun; Keith M Faucher; Michelle Houston; Daniel Grande; Elliot L Chaikof
Journal:  J Am Chem Soc       Date:  2002-06-26       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.